Jacobs Levy Equity Management, Inc Bluebird Bio, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.85 - $1.26 $282,791 - $419,196	332,696 New	332,696 $326,000
Q4 2023 Feb 14, 2024	SELL	$1.32 - $4.83 $1.46 Million - $5.34 Million	-1,106,575 Reduced 60.09%	735,009 $1.01 Million
Q3 2023 Nov 16, 2023	SELL	$3.02 - $4.05 $752,964 - $1.01 Million	-249,326 Reduced 11.92%	1,841,584 $5.6 Million
Q2 2023 Aug 14, 2023	BUY	$2.79 - $5.03 $2.06 Million - $3.72 Million	738,987 Added 54.66%	2,090,910 $6.88 Million
Q1 2023 May 15, 2023	BUY	$3.14 - $8.22 $1.87 Million - $4.91 Million	596,779 Added 79.03%	1,351,923 $4.3 Million
Q4 2022 Feb 14, 2023	BUY	$5.77 - $8.49 $3.62 Million - $5.33 Million	627,917 Added 493.54%	755,144 $5.23 Million
Q3 2022 Nov 15, 2022	SELL	$3.75 - $7.39 $16,938 - $33,380	-4,517 Reduced 3.43%	127,227 $805,000
Q2 2022 Aug 15, 2022	SELL	$2.94 - $5.23 $772,943 - $1.37 Million	-262,906 Reduced 66.62%	131,744 $545,000
Q1 2022 May 16, 2022	SELL	$4.07 - $10.6 $29,853 - $77,751	-7,335 Reduced 1.82%	394,650 $1.91 Million
Q4 2021 Feb 14, 2022	SELL	$8.96 - $16.31 $11,119 - $20,240	-1,241 Reduced 0.31%	401,985 $4.02 Million
Q3 2021 Nov 15, 2021	SELL	$11.24 - $21.0 $4.58 Million - $8.55 Million	-407,147 Reduced 50.24%	403,226 $7.71 Million
Q2 2021 Aug 16, 2021	BUY	$18.04 - $22.09 $969,307 - $1.19 Million	53,731 Added 7.1%	810,373 $25.9 Million
Q1 2021 May 17, 2021	BUY	$16.59 - $33.89 $3.53 Million - $7.22 Million	212,927 Added 39.16%	756,642 $22.8 Million
Q4 2020 Feb 16, 2021	BUY	$27.5 - $37.92 $3.01 Million - $4.15 Million	109,319 Added 25.17%	543,715 $23.5 Million
Q3 2020 Nov 16, 2020	BUY	$34.44 - $43.75 $5.85 Million - $7.43 Million	169,811 Added 64.18%	434,396 $23.4 Million
Q2 2020 Aug 17, 2020	BUY	$27.12 - $45.97 $3.72 Million - $6.31 Million	137,318 Added 107.9%	264,585 $16.2 Million
Q1 2020 May 15, 2020	BUY	$26.16 - $63.5 $3.33 Million - $8.08 Million	127,267 New	127,267 $5.85 Million
Q2 2018 Aug 14, 2018	SELL	$99.64 - $127.59 $133,517 - $170,970	-1,340 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$105.8 - $150.94 $141,772 - $202,259	1,340 New	1,340 $229,000

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$5.71 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$3.88 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$1.73 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$1.73 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$1.42 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account